Sandu Pharmaceuticals informs about quarterly statement of investor complaints

12 Apr 2016 Evaluate

Sandu Pharmaceuticals has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Sandu Pharmaceutical Share Price

38.64 -0.10 (-0.26%)
31-Dec-2025 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.20
Dr. Reddys Lab 1262.70
Cipla 1493.35
Zydus Lifesciences 906.05
Lupin 2096.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×